APLN and Alzheimer disease: Some studies have reported that Apelin-13 reduces the number of Aβ plaques in the hippocampus [41], and this needs to be further investigated in our future studies to clarify whether the anti-AD effect of Apelin-13 is related to the reduction in Aβ plaques.